158 related articles for article (PubMed ID: 38057786)
1. Increased circulating FGF21 level predicts the burden of metabolic demands and risk of vascular diseases in adults with type 2 diabetes.
Liu Z; Peng Y; Li S; Lin Y; Huang Y; Chen W; Bao C; Zhou Z; Lin Z; Chen L
BMC Endocr Disord; 2023 Dec; 23(1):272. PubMed ID: 38057786
[TBL] [Abstract][Full Text] [Related]
2. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events.
Wu L; Qian L; Zhang L; Zhang J; Zhou J; Li Y; Hou X; Fang Q; Li H; Jia W
J Am Heart Assoc; 2020 Jun; 9(11):e015226. PubMed ID: 32431189
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 resistance is associated with body shape in patients with type 2 diabetes complicating hypertension.
Gan J; Duan Z; Tang L; Liu Z; Tian H; Wu M; Bi Y; Pan X; Wang W; Gao X; Wang N; Lin Z; Yang H
Front Cardiovasc Med; 2023; 10():1168047. PubMed ID: 37424900
[TBL] [Abstract][Full Text] [Related]
5. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
[TBL] [Abstract][Full Text] [Related]
6. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
[TBL] [Abstract][Full Text] [Related]
7. Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients.
Esteghamati A; Momeni A; Abdollahi A; Khandan A; Afarideh M; Noshad S; Nakhjavani M
Ann Endocrinol (Paris); 2016 Oct; 77(5):586-592. PubMed ID: 27106505
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 21 association with subclinical atherosclerosis and arterial stiffness in type 2 diabetes.
Yafei S; Elsewy F; Youssef E; Ayman M; El-Shafei M
Diabetes Metab Syndr; 2019; 13(1):882-888. PubMed ID: 30641825
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
[TBL] [Abstract][Full Text] [Related]
10. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
[TBL] [Abstract][Full Text] [Related]
11. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus.
Lee CH; Woo YC; Chow WS; Cheung CYY; Fong CHY; Yuen MMA; Xu A; Tse HF; Lam KSL
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588089
[TBL] [Abstract][Full Text] [Related]
12. Circulating Fibroblast Growth Factor 21 and Total Testosterone in Type 2 Diabetes Mellitus Men With Coronary Heart Disease.
Mei Y; Lyu Y; Zhao Z; Li Y
Front Endocrinol (Lausanne); 2022; 13():912243. PubMed ID: 35909513
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Serum FGF21 and vWF Expression and Carotid Atherosclerosis in Elderly Patients with Hypertension.
Bian J; Chen L; Li Q; Zhao Y; Yin D; Sun S
J Healthc Eng; 2022; 2022():6777771. PubMed ID: 35242298
[TBL] [Abstract][Full Text] [Related]
14. Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes.
Hong ES; Lim C; Choi HY; Lee YK; Ku EJ; Moon JH; Park KS; Jang HC; Choi SH
BMJ Open Diabetes Res Care; 2019; 7(1):e000776. PubMed ID: 31798902
[TBL] [Abstract][Full Text] [Related]
15. Association of serum C1Q/TNF-related protein 4 levels with carotid atherosclerosis in subjects with type 2 diabetes mellitus: A cross-sectional study.
Liu Z; Han J; Wang Y; Yang M; Niu L; Shi B
Clin Chim Acta; 2022 Jun; 531():337-341. PubMed ID: 35525266
[TBL] [Abstract][Full Text] [Related]
16. Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis.
Takebe N; Hasegawa Y; Matsushita Y; Chiba H; Onodera K; Kinno H; Oda T; Nagasawa K; Segawa T; Takahashi Y; Okada K; Ishigaki Y
Medicine (Baltimore); 2023 Sep; 102(35):e34797. PubMed ID: 37657012
[TBL] [Abstract][Full Text] [Related]
17. Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients.
Zhang X; Hu Y; Zeng H; Li L; Zhao J; Zhao J; Liu F; Bao Y; Jia W
Cardiovasc Diabetol; 2015 Mar; 14():32. PubMed ID: 25850006
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes.
Lu J; Yu H; Mo Y; Ma X; Hao Y; Lu W; Li H; Bao Y; Zhou J; Jia W
PLoS One; 2015; 10(11):e0142207. PubMed ID: 26540514
[TBL] [Abstract][Full Text] [Related]
19. Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis.
Ong KL; Campbell S; Wu BJ; McClelland RL; Kokkinos J; Szklo M; Polak JF; Allison MA; Rye KA
Atherosclerosis; 2019 Aug; 287():46-53. PubMed ID: 31212234
[TBL] [Abstract][Full Text] [Related]
20. Distinct changes in serum fibroblast growth factor 21 levels in different subtypes of diabetes.
Xiao Y; Xu A; Law LS; Chen C; Li H; Li X; Yang L; Liu S; Zhou Z; Lam KS
J Clin Endocrinol Metab; 2012 Jan; 97(1):E54-8. PubMed ID: 22013098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
